BTN3A1 and cancer: The intracellular domain of butyrophilin 3A1 (BTN3A1) molecule, which is expressed on the cancer cells binds to the accumulated IPP, and then interacts with BTN2A1 to bind and activate the TCR on Vγ9Vδ2 T cells109 (Figure 2A).